ATE279188T1 - Pharmazeutische zusammensetzungen enthaltend gaba-analogen und ein antivirales mittel zur behandlung von herpes zoster - Google Patents

Pharmazeutische zusammensetzungen enthaltend gaba-analogen und ein antivirales mittel zur behandlung von herpes zoster

Info

Publication number
ATE279188T1
ATE279188T1 AT99930482T AT99930482T ATE279188T1 AT E279188 T1 ATE279188 T1 AT E279188T1 AT 99930482 T AT99930482 T AT 99930482T AT 99930482 T AT99930482 T AT 99930482T AT E279188 T1 ATE279188 T1 AT E279188T1
Authority
AT
Austria
Prior art keywords
treatment
pharmaceutical compositions
compositions containing
antiviral agent
herpes zoster
Prior art date
Application number
AT99930482T
Other languages
German (de)
English (en)
Inventor
Leslie Magnus
Catherine A Segal
Original Assignee
Warner Lambert Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co filed Critical Warner Lambert Co
Application granted granted Critical
Publication of ATE279188T1 publication Critical patent/ATE279188T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Oncology (AREA)
  • Pain & Pain Management (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Molecular Biology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT99930482T 1998-07-09 1999-06-18 Pharmazeutische zusammensetzungen enthaltend gaba-analogen und ein antivirales mittel zur behandlung von herpes zoster ATE279188T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US9217198P 1998-07-09 1998-07-09
PCT/US1999/013947 WO2000002592A1 (en) 1998-07-09 1999-06-18 Pharmaceutical composition containinig gaba analogs and an antiviral agent to treat shingles

Publications (1)

Publication Number Publication Date
ATE279188T1 true ATE279188T1 (de) 2004-10-15

Family

ID=22231986

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99930482T ATE279188T1 (de) 1998-07-09 1999-06-18 Pharmazeutische zusammensetzungen enthaltend gaba-analogen und ein antivirales mittel zur behandlung von herpes zoster

Country Status (17)

Country Link
EP (1) EP1093366B1 (cg-RX-API-DMAC7.html)
JP (1) JP2002520300A (cg-RX-API-DMAC7.html)
KR (1) KR20010071776A (cg-RX-API-DMAC7.html)
AT (1) ATE279188T1 (cg-RX-API-DMAC7.html)
AU (1) AU765246B2 (cg-RX-API-DMAC7.html)
CA (1) CA2332929C (cg-RX-API-DMAC7.html)
DE (1) DE69921137T2 (cg-RX-API-DMAC7.html)
DK (1) DK1093366T3 (cg-RX-API-DMAC7.html)
ES (1) ES2230863T3 (cg-RX-API-DMAC7.html)
ID (1) ID27395A (cg-RX-API-DMAC7.html)
NO (1) NO20010116D0 (cg-RX-API-DMAC7.html)
NZ (2) NZ508489A (cg-RX-API-DMAC7.html)
PL (1) PL345337A1 (cg-RX-API-DMAC7.html)
PT (1) PT1093366E (cg-RX-API-DMAC7.html)
SI (1) SI1093366T1 (cg-RX-API-DMAC7.html)
WO (1) WO2000002592A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA200007169B (cg-RX-API-DMAC7.html)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU4334900A (en) 1999-04-09 2000-11-14 Euro-Celtique S.A. Sodium channel blocker compositions and the use thereof
US8048917B2 (en) 2005-04-06 2011-11-01 Xenoport, Inc. Prodrugs of GABA analogs, compositions and uses thereof
CN1274306C (zh) 2001-09-03 2006-09-13 纽朗制药有限公司 包含加巴喷丁或其类似物和α-氨基酰胺的药物组合物及其止痛应用
IN266803B (cg-RX-API-DMAC7.html) 2005-12-22 2015-06-03 Newron Pharm Spa
MX2007006093A (es) * 2007-05-21 2009-02-25 World Trade Imp Export Wtie Ag Composicion farmaceutica que comprende la combinacion de un agente anticonvulsivo y un agente antiviral.
KR20160095358A (ko) 2015-02-03 2016-08-11 고려대학교 산학협력단 우고닌 또는 이의 약학적으로 허용 가능한 염을 유효성분으로 함유하는 헤르페스 바이러스 감염 질환의 예방 또는 치료용 약학적 조성물

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL111138A (en) * 1993-10-05 1997-04-15 Smithkline Beecham Plc Pharmaceutical compositions comprising penciclovir and/or its bioprecursor and/or its derivatives for the treatment and prophylaxis of post-herpetic neuralgia
GB9321394D0 (en) * 1993-10-16 1993-12-08 Smihtkline Beecham P L C Pharmaceuticals
EA001214B1 (ru) * 1996-03-14 2000-12-25 Варнер-Ламберт Компани Новые мостиковые циклические аминокислоты как фармацевтически применимые вещества
EP0934061B3 (en) * 1996-07-24 2015-01-21 Warner-Lambert Company LLC Isobutylgaba and its derivatives for the treatment of pain

Also Published As

Publication number Publication date
EP1093366B1 (en) 2004-10-13
PT1093366E (pt) 2005-02-28
ES2230863T3 (es) 2005-05-01
DE69921137T2 (de) 2006-02-02
ZA200007169B (en) 2002-03-04
WO2000002592A1 (en) 2000-01-20
JP2002520300A (ja) 2002-07-09
NO20010116L (no) 2001-01-08
CA2332929A1 (en) 2000-01-20
PL345337A1 (en) 2001-12-17
NZ508489A (en) 2004-06-25
AU765246B2 (en) 2003-09-11
DE69921137D1 (de) 2004-11-18
ID27395A (id) 2001-04-05
NO20010116D0 (no) 2001-01-08
KR20010071776A (ko) 2001-07-31
CA2332929C (en) 2005-05-31
EP1093366A1 (en) 2001-04-25
DK1093366T3 (da) 2004-12-06
NZ525623A (en) 2005-08-26
AU4701699A (en) 2000-02-01
SI1093366T1 (en) 2005-02-28

Similar Documents

Publication Publication Date Title
BR9911887A (pt) Método para o tratamento da insÈnia
ATE461698T1 (de) Gaba-analoga zur verhütung und behandlung gastrointestinaler beschwerden
IS2706B (is) Lyfjasamsetning sem inniheldur róteindadæluhindra
ATE241351T1 (de) Isobutylgaba und dessen derivate zur schmerzbehandlung
DK0758895T3 (da) Sublinguale dosisformer indeholdende apomorphin til anvendelse ved behandling af erektil dysfunktion
ATE257386T1 (de) Pharmazeutische zusammensetzungen enthaltend eine mischung von selbstvernetzter und nichtselbstvernetzter hyaluronsäure zur behandlung von arthropathien
FI945426A7 (fi) GABA- ja L-glutamiinihappoanalogit kohtauksenvastaiseen käsittelyyn
BR9713465A (pt) Inibidores metalotprotease de amina cìclica sibstituìda
ATE206916T1 (de) Zusammensetzungen zur erhöhung der konzentration und/oder beweglichkeit von samenzellen in menschen
DE69921137D1 (de) Pharmazeutische zusammensetzungen enthaltend gaba-analogen und ein antivirales mittel zur behandlung von herpes zoster
FR2590805B1 (fr) Procede et installation de neutralisation de fumees acides provenant notamment de la combustion de residus
ATE376445T1 (de) Synergistische hemmung von viralreplikation durch langkettigen kohlenwasserstoffe und nucleosid- analoge
BR9911917A (pt) Composições compreendendo análogos de gaba e cafeìna
IS2279B (is) Notkun á hliðstæðum gamma-amínósmjörsýru (GABA) áborð við GABA-pentín til vinnslu lyfs til meðferðar á bólgusjúkdómum
EP0221572A3 (en) N-substituted 3-piperidine-or 3-pyridine-carboxylic acids and derivatives thereof
DE60134337D1 (de) N-alkylierte gaba verbindungen, verfahren zu deren
ATE77954T1 (de) Pharmazeutisches praeparat zur behandlung von lebererkrankungen.
ATE383161T1 (de) Kombination von product r mit einem antiviralen mittel in der behandlung von hiv infektionen
DE69629282D1 (de) Verwendung eines pyruvatdehydrogenaseaktivators zur behandlung der ischämie in gliedern
BR9911950A (pt) Composição farmacêutica contendo análogos gaba e um agente antiviral para tratamento de herpes zoster
DE69031038D1 (de) Peptidderivate
BR9911943A (pt) Composições compreendendo análogos gaba e um descongestionante para aliviar dor de cabeça de sino
ATE305778T1 (de) Behandlung von nierenkolik mit gaba-analogen
BR9812265A (pt) Uso de análogos de gaba, tais como gabapentina, na fabricação de um medicamento para o tratamento de doenças inflamatórias.
RU97111543A (ru) Способ лечения неврологических нарушений, связанных с хронической формой врожденной вирусной инфекции

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1093366

Country of ref document: EP

REN Ceased due to non-payment of the annual fee